Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA-Reference-Cited by-同舟云学术

Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA

Published:2000-03-15 Issue:6 Volume:105 Page:777-782
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Rizzardi G. Paolo,De Boer Rob J.,Hoover Shelley,Tambussi Giuseppe,Chapuis Aude,Halkic Nermin,Bart Pierre-Alexandre,Miller Veronica,Staszewski Schlomo,Notermans Daan W.,Perrin Luc,Fox Cecil H.,Lange Joep M.A.,Lazzarin Adriano,Pantaleo Giuseppe

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference33 articles.

1. HIV-1 Protease Inhibitors

2. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

3. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

4. HIV-Protease Inhibitors

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study;BMC Cancer;2023-09-21

2. Modelling the evolution of HIV ‐1 virulence in response to imperfect therapy and prophylaxis;Evolutionary Applications;2017-02-11

3. Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels;BMC Infectious Diseases;2016-06-21

4. Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis;PLOS ONE;2015-08-11

5. La cinétique de la charge virale après le début d’un traitement antirétroviral : une baisse plus rapide de la charge virale a-t-elle vraiment un intérêt ?;Pathologie Biologie;2010-12